Seeing Is Believing
PRLD is currently covered by 4 analysts with an average price target of $4.47. This is a potential upside of $0.4 (9.83%) from yesterday's end of day stock price of $4.07.
Prelude Therapeutics 's activity chart (see below) currently has 16 price targets and 25 ratings on display. The stock rating distribution of PRLD is 58.33% BUY, 33.33% HOLD and 8.33% SELL.
Analysts average stock forecasts to be materialized ratio is 34.64% with an average time for these price targets to be met of 103.25 days.
Highest price target for PRLD is $5, Lowest price target is $4, average price target is $4.47.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 20-Feb-2024. First documented stock forecast 20-Oct-2020.
Currently out of the existing stock ratings of PRLD, 7 are a BUY (58.33%), 4 are a HOLD (33.33%), 1 are a SELL (8.33%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
$1.13 (29.20%)
5
2 months 9 days ago
2/8 (25%)
$0.84 (20.19%)
104
Sell
4
$0.13 (3.36%)
10
4 months 10 days ago
2/7 (28.57%)
$-0.04 (-0.99%)
4
5
$1.13 (29.20%)
12
8 months 25 days ago
1/4 (25%)
$1.33 (36.24%)
251
Hold
6
$2.13 (55.04%)
10
1 years 5 months 8 days ago
3/5 (60%)
$-0.53 (-8.12%)
54
What is PRLD (Prelude Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on PRLD (Prelude Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on PRLD (Prelude Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?
Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?
Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?